Kriz J, Hysperska V, Bebrova E, Roznetinska M
Infect Prev Pract. 2024; 6(1):100340.
PMID: 38357521
PMC: 10865020.
DOI: 10.1016/j.infpip.2024.100340.
Wilson J, Sanderson W, Westgate P, Winter K, Forster D
Infect Prev Pract. 2023; 5(4):100310.
PMID: 37767313
PMC: 10520311.
DOI: 10.1016/j.infpip.2023.100310.
Gomes M, de Lima E, Martins Aires C, Pereira P, Yim J, Silva F
Sci Rep. 2023; 13(1):6238.
PMID: 37069157
PMC: 10110528.
DOI: 10.1038/s41598-023-31901-4.
Obradovic M, Malesevic M, Di Luca M, Kekic D, Gajic I, McAuliffe O
Viruses. 2023; 15(3).
PMID: 36992337
PMC: 10052179.
DOI: 10.3390/v15030628.
Martinez D, Cai J, Lin G, Goodman K, Paul R, Lessler J
J Hosp Infect. 2023; 136:1-7.
PMID: 36907332
PMC: 10315994.
DOI: 10.1016/j.jhin.2023.02.016.
Comparative Proteomics of Outer Membrane Vesicles from Polymyxin-Susceptible and Extremely Drug-Resistant Klebsiella pneumoniae.
Hussein M, Jasim R, Gocol H, Baker M, Thombare V, Ziogas J
mSphere. 2023; 8(1):e0053722.
PMID: 36622250
PMC: 9942579.
DOI: 10.1128/msphere.00537-22.
Role of tigecycline in the treatment of urinary tract infections: a systematic review of published case reports.
Charles R, Adhikari S, Mittal A, Chaudhuri S, Gupta M, Khot W
Infez Med. 2022; 30(4):516-524.
PMID: 36482959
PMC: 9715003.
DOI: 10.53854/liim-3004-5.
Inorganic Nanoparticles and Composite Films for Antimicrobial Therapies.
Spirescu V, Chircov C, Grumezescu A, Vasile B, Andronescu E
Int J Mol Sci. 2021; 22(9).
PMID: 33925617
PMC: 8123905.
DOI: 10.3390/ijms22094595.
Isolation and Characterization of Phages for Phage Therapy.
Townsend E, Kelly L, Gannon L, Muscatt G, Dunstan R, Michniewski S
Phage (New Rochelle). 2021; 2(1):26-42.
PMID: 33796863
PMC: 8006926.
DOI: 10.1089/phage.2020.0046.
Iron Acquisition Systems of Gram-negative Bacterial Pathogens Define TonB-Dependent Pathways to Novel Antibiotics.
Klebba P, Newton S, Six D, Kumar A, Yang T, Nairn B
Chem Rev. 2021; 121(9):5193-5239.
PMID: 33724814
PMC: 8687107.
DOI: 10.1021/acs.chemrev.0c01005.
In vitro Combined Inhibitory Activities of β-Lactam Antibiotics and Clavulanic Acid Against -Positive .
Peng M, Han R, Guo Y, Zheng Y, Yang F, Xu X
Infect Drug Resist. 2021; 14:361-368.
PMID: 33564244
PMC: 7866911.
DOI: 10.2147/IDR.S292612.
Efficacy and safety of tigecycline for complicated urinary tract infection: a systematic review.
Liu Y, Le K, Shi H, Zhang Z, Cui M, Zhong H
Transl Androl Urol. 2021; 10(1):292-299.
PMID: 33532318
PMC: 7844507.
DOI: 10.21037/tau-20-959.
CAUTI's next top model - Model dependent biofilm inhibition by bacteriophages and antimicrobials.
Townsend E, Moat J, Jameson E
Biofilm. 2020; 2:100038.
PMID: 33381752
PMC: 7762788.
DOI: 10.1016/j.bioflm.2020.100038.
Evolution of Colistin Resistance in the Klebsiella pneumoniae Complex Follows Multiple Evolutionary Trajectories with Variable Effects on Fitness and Virulence Characteristics.
Janssen A, Doorduijn D, Mills G, Rogers M, Bonten M, Rooijakkers S
Antimicrob Agents Chemother. 2020; 65(1).
PMID: 33139278
PMC: 7927857.
DOI: 10.1128/AAC.01958-20.
Insight into the Possible Use of the Predator as a Probiotic.
Bonfiglio G, Neroni B, Radocchia G, Marazzato M, Pantanella F, Schippa S
Nutrients. 2020; 12(8).
PMID: 32731403
PMC: 7468853.
DOI: 10.3390/nu12082252.
Outbreak of colistin-resistant organisms at a tertiary hospital in Riyadh, Saudi Arabia, 2016.
Al Mayahi Z, Kamel S, Amer H, Beatty M
Pan Afr Med J. 2020; 34:162.
PMID: 32153702
PMC: 7046114.
DOI: 10.11604/pamj.2019.34.162.19998.
Characterization of Resistance in Gram-Negative Urinary Isolates Using Existing and Novel Indicators of Clinical Relevance: A 10-Year Data Analysis.
Gajdacs M, Batori Z, Abrok M, Lazar A, Burian K
Life (Basel). 2020; 10(2).
PMID: 32054054
PMC: 7175163.
DOI: 10.3390/life10020016.
The Role of Fecal Microbiota Transplantation in Reducing Intestinal Colonization With Antibiotic-Resistant Organisms: The Current Landscape and Future Directions.
Woodworth M, Hayden M, Young V, Kwon J
Open Forum Infect Dis. 2019; 6(7).
PMID: 31363779
PMC: 6667716.
DOI: 10.1093/ofid/ofz288.
Infections with Carbapenem-Resistant Gram-Negative Bacteria are a Serious Problem Among Critically Ill Children: A Single-Centre Retrospective Study.
Aygun F, Aygun F, Varol F, Durak C, Cokugras H, Camcioglu Y
Pathogens. 2019; 8(2).
PMID: 31117259
PMC: 6630812.
DOI: 10.3390/pathogens8020069.
Resistance diagnostics as a public health tool to combat antibiotic resistance: A model-based evaluation.
McAdams D, Waldetoft K, Tedijanto C, Lipsitch M, Brown S
PLoS Biol. 2019; 17(5):e3000250.
PMID: 31095567
PMC: 6522007.
DOI: 10.1371/journal.pbio.3000250.